SCHEMBL19981885

SCHEMBL19981885

CC1=CCCN(C(=O)CNC(=O)OC(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
MEN1 O00255 1/20 0.51
TSHR P16473 1/20 0.51
KMT2A Q03164 1/20 0.51
SIGMAR1 Q99720 3/20 0.48
MMP1 P03956 2/20 0.40
MMP13 P45452 2/20 0.40
MMP9 P14780 1/20 0.40
FNTA P49354 2/20 0.38
FNTB P49356 2/20 0.38
NAMPT P43490 2/20 0.37
ADAM17 P78536 1/20 0.36
DRD2 P14416 3/20 0.35
DPP8 Q6V1X1 2/20 0.35
DPP9 Q86TI2 2/20 0.35
NPFFR1 Q9GZQ6 1/20 0.35
NPFFR2 Q9Y5X5 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
CTSD P07339 1/20 0.34
CTSL P07711 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211627 0.80 ALDH1A1 (0.58) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL12519920 0.77 ESR2 (0.47) ALDH1A1MEN1KMT2A
SCHEMBL1329658 0.75 TSHR (0.62) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL4472678 0.74 TSHR (0.60) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL6783021 0.74 MEN1 (0.53) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL6230603 0.74 NAMPT (0.59) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL19824267 0.74 MEN1 (0.48) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL19981882 0.73 KMT2A (0.48) MEN1TSHRKMT2ACTSLCTSB
SCHEMBL19820848 0.73 KMT2A (0.56) ALDH1A1MEN1TSHRKMT2ASIGMAR1
SCHEMBL25313503 0.73 ALDH1A1 (0.59) ALDH1A1MEN1TSHRKMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018053222-A1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RESEARCH TRAINGLE INSTITUTE (US) 2018-03-22 WO disclosed